Lorcaserin Extended-Release Tablets and Ocrelizumab Intravenous
Determining the interaction of Lorcaserin Extended-Release Tablets and Ocrelizumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
Generic Name: ocrelizumab
Brand name: Ocrevus
Synonyms: Ocrelizumab (Intravenous), Ocrelizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lorcaserin Extended-Release Tablets-Ocrevus
- Lorcaserin Extended-Release Tablets-Octagam
- Lorcaserin Extended-Release Tablets-Octagam Gammagard S/D
- Lorcaserin Extended-Release Tablets-Octocaine
- Lorcaserin Extended-Release Tablets-Octocaine 100
- Lorcaserin Extended-Release Tablets-OctreoScan
- Ocrelizumab Intravenous-Lorcaserin Hydrochloride
- Ocrelizumab Intravenous-Lorcaserin Tablets
- Ocrelizumab Intravenous-Lorcet
- Ocrelizumab Intravenous-Lorcet Plus
- Ocrelizumab Intravenous-Lorcet Tablets
- Ocrelizumab Intravenous-Lorlatinib